Itai Glinert - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Itai Glinert

Showing results (31-40 of 34) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 34 results.

Archives of Toxicology|January 15, 2022

Preliminary nonclinical safety and immunogenicity of an rVSV-ΔG-SARS-CoV-2-S vaccine in mice, hamsters, rabbits and pigsNoa Madar-Balakirski, Amir Rosner, Sharon Melamed, et al.

JCI Insight|May 11, 2021

Mice with induced pulmonary morbidities display severe lung inflammation and mortality following exposure to SARS-CoV-2Reut Falach, Liat Bar-On, Shlomi Lazar, et al.

Nature Communications|December 17, 2020

A single dose of recombinant VSV-∆G-spike vaccine provides protection against SARS-CoV-2 challengeYfat Yahalom-Ronen, Hadas Tamir, Sharon Melamed, et al.

Science (New York, N.Y.)|November 9, 2023

Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitorsMelissa L Boby, Daren Fearon, Matteo Ferla, et al.

Pageof 4

Search research articles

Showing results (31-40 of 34) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 34 results.

Archives of Toxicology|January 15, 2022

Preliminary nonclinical safety and immunogenicity of an rVSV-ΔG-SARS-CoV-2-S vaccine in mice, hamsters, rabbits and pigsNoa Madar-Balakirski, Amir Rosner, Sharon Melamed, et al.

JCI Insight|May 11, 2021

Mice with induced pulmonary morbidities display severe lung inflammation and mortality following exposure to SARS-CoV-2Reut Falach, Liat Bar-On, Shlomi Lazar, et al.

Nature Communications|December 17, 2020

A single dose of recombinant VSV-∆G-spike vaccine provides protection against SARS-CoV-2 challengeYfat Yahalom-Ronen, Hadas Tamir, Sharon Melamed, et al.

Science (New York, N.Y.)|November 9, 2023

Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitorsMelissa L Boby, Daren Fearon, Matteo Ferla, et al.

Pageof 4